World Journal of Surgery

, Volume 30, Issue 8, pp 1371–1373

Biomedical Industrial Sponsorship and Its Impact on the Medical Literature



  1. 1.
    National Institute for Health Care Management Foundation. Prescription drug expenditures in 2001: another year of escalating costs., 2002
  2. 2.
    Montaner JSG, O’Shaughnessy MV, Schechter T. Industry-sponsored clinical research: a double edged sword. Lancet 2001;358:1893PubMedCrossRefGoogle Scholar
  3. 3.
    The Association of the British Pharmaceutical Industry. Facts and statistics from the pharmaceutical industry., 2005
  4. 4.
    The International Committee of Medical Journal Editors (ICMJE)., 2004
  5. 5.
    Chalmers I. Underreporting research is scientific misconduct. JAMA 1990;263:1405PubMedCrossRefGoogle Scholar
  6. 6.
    Lexchin J, Bero LA, Djulbegovic B, et al. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003;326:1167PubMedCrossRefGoogle Scholar
  7. 7.
    Bhandari M, Busse JW, Jackowski D, et al. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. Can Med Assoc J 2004;170:477Google Scholar
  8. 8.
    Melander H, Ahlqvist-Rastad J, Meijer B, et al. Evidence b(i)ased medicine: selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. BMJ 2003;326:xCrossRefGoogle Scholar
  9. 9.
    Als-Nielsen B, Chen W, Gluud C, et al. Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events. JAMA 2003;290:921PubMedCrossRefGoogle Scholar
  10. 10.
    Cho MK, Bero LA. The quality of drug studies published in symposium proceedings. Ann Intern Med 1996;124:485PubMedGoogle Scholar
  11. 11.
    Bekelman JE, Li Y, Gross GP. Scope and impact of financial conflicts of interest in biomedical research. JAMA 2003;289:454PubMedCrossRefGoogle Scholar
  12. 12.
    Choudhry NK, Stelfox HT, Detsky AS. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA 2002;287:612PubMedCrossRefGoogle Scholar
  13. 13.
    Stelfox HT, Chua G, O’Rourke K, et al. Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med 1998;338:101PubMedCrossRefGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2006

Authors and Affiliations

  1. 1.The Centre for Evidence in TransplantationThe Royal College of Surgeons of England and the LSHTM, University of LondonLondonUK

Personalised recommendations